[HTML] sciencedirect.com

[HTML][HTML] Study on the effect of Irbesartan on atrial fibrillation recurrence in Kumamoto: atrial fibrillation suppression trial (SILK study)

H Yamabe, K Kaikita, T Matsumura, A Iwasa… - Journal of …, 2018 - Elsevier
Background Experimental studies suggest that angiotensin II-receptor blockers can
influence atrial remodeling and may prevent atrial fibrillation (AF). Therefore, we …
被引用次数：11 相关文章

[引用][C] Study on the Effect of Irbesartan on Atrial Fibrillation Recurrence in Kumamoto: Atrial Fibrillation Suppression Trial (SILK study)

H Yamabe, K Kaikita, T Matsumura, A Iwasa… - Journal of …, 2018 - cir.nii.ac.jp
Study on the Effect of Irbesartan on Atrial Fibrillation Recurrence in Kumamoto: Atrial
Fibrillation Suppression Trial (SILK study) | CiNii Research CiNii 国立情報学研究所 学術情報 …

Study on the Effect of Irbesartan on Atrial Fibrillation Recurrence in Kumamoto: Atrial Fibrillation Suppression Trial (SILK study).

H Yamabe, K Kaikita, T Matsumura, A Iwasa… - Journal of …, 2017 - europepmc.org
Background Experimental studies suggest that angiotensin II-receptor blockers can
influence atrial remodeling and may prevent atrial fibrillation (AF). Therefore, we …
[HTML] journal-of-cardiology.com

[HTML][HTML] Study on the Effect of Irbesartan on Atrial Fibrillation Recurrence in Kumamoto: Atrial Fibrillation Suppression Trial (SILK study)

H Yamabe, K Kaikita, T Matsumura… - Journal of …, 2018 - journal-of-cardiology.com
Background Experimental studies suggest that angiotensin II-receptor blockers can
influence atrial remodeling and may prevent atrial fibrillation (AF). Therefore, we …

Study on the Effect of Irbesartan on Atrial Fibrillation Recurrence in Kumamoto: Atrial Fibrillation Suppression Trial (SILK study)

H Yamabe, K Kaikita, T Matsumura… - Journal of …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Experimental studies suggest that angiotensin II-receptor blockers can
influence atrial remodeling and may prevent atrial fibrillation (AF). Therefore, we …